Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today Podcasts

Accelerating innovation and implementation of health technology
Subscribe
Advertisement
WP Engine-Wordpress Hosting

Latest Episodes

Showing 1 - 8 of 159

Coffee Talk: Why is Digital Health Important to Biopharmaceutical Companies?

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services. Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care. One of those organizations is Bayer. In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy. This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.   The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today. The deadline to apply is June 20, 2021. Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host Links Connect with Dan: Twitter | Linkedin Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram
June 11, 2021 by Digital Health Today 360°

S12: #112 “The dumbest thing I'd ever done…that began the career path that I still am on today” with Dr. David E. Albert, Founder of AliveCor

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do. Each year, over 20,000 students enrolled in medical schools across the US. Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years. So why do people who are on a path to a successful career in medicine decide to become entrepreneurs? Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur." Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand. Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care. Guest Links and Resources: Connect with Dr. Dave Albert: Twitter | LinkedIn | Connect with AliveCor: Website | Twitter | LinkedIn | YouTube Dr. Albert's 2011 YouTube video showing the AliveCor ECG Host Links Twitter @healthtechdan Linkedin: https://www.linkedin.com/in/dankendall/ Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Roche Takeda

Ep23: Conclusion: Reflecting on DTx Limited Edition Series

In this final episode of Digital Therapeutics Edition, Eugene and his journalistic partner, Brian Dolan, reflect on the lessons learned, guest experts, and inspiring stories featured in season one. Brian is a journalist and the founder and lead writer of Exits & Outcomes, and in each episode, he asked the guests a pointed and challenging question about their digital solutions or their outlook on the DTx industry.  It's been an eventful five months, Brian says -- companies have been bought, merged, and sold, and have raised impressive rounds of funding -- but there are other areas that have seen little progress since the podcast was launched. There may be a season 2 of Digital Therapeutics Edition, but in the meantime, head over to healthxl.com/dtx to continue the conversation with Eugene and other experts. What do you think the future of DTx will look like?  >>Click here to read the transcript Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep22: Clinically-Validated DTx Solutions for Unmet Needs

Abhishek Shah, the CEO and founder of Wellthy Therapeutics, is driven by the challenge of improving care delivery and outcomes for serious or chronic diseases like hypertension, type 2 diabetes, and kidney disease. Abhishek decided to start Wellthy after a successful career as an investor; he was inspired by the incredible ideas of other entrepreneurs, and tired of sitting on the sidelines, decided to build something himself.  Eugene and Abhishek talked back in December, and in that time, Wellthy has laid the groundwork for expansion throughout Asia Pacific and Europe. Eugene and Abhishek talk about his efforts to get investors to back Wellthy, the technology and regulatory landscape for DTx in South Asia, and whether Wellthy is facing competition from other industry players like Apollo during the COVID-19 pandemic. >>Click here to read the transcript Guest Links and Resources: Connect with Abhishek Shah: LinkedIn | Twitter Visit Wellthy Therapeutics: Twitter | LinkedIn | Facebook | Instagram | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep21: Investing in Prescription DTx

Edward Kliphuis says his love for investing in digital health comes from his love of "playing with toys" and imagining the possible benefit to health outcomes if "damn cool" solutions are scaled significantly.  M Ventures backs many impressive companies-- like BioLink, Sonde Health, and Akili. In this episode, Ed talks to Eugene about M Ventures' founding philosophy (how to cut delayed feedback cycles, which M Ventures views as the biggest threat to humanity), approach to investing, and discusses some of the drivers of capital injections in the DTx space. Also, Ed offers his insight into what makes for a truly successful DTx company. >>Click here to read the transcript Guest Links and Resources: Connect with Edward Kliphuis: LinkedIn Visit Amadeus Capital Partners: Twitter | LinkedIn | Website Visit M Ventures: LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep20: Investing in DTx Businesses

Will Gibbs came to Octopus Ventures via a circuitous route - which interestingly, included setting up a rare breed pig farm in his native Essex. He landed in venture capital because he loves to build things - especially large-scale solutions for "taboo" or overlooked medical conditions like substance addiction, menopause, and acne.  Will and Eugene peek underneath the hood of venture capital. They discuss Octopus Ventures' investments in companies like Big Health and Quit Genius, the ins and outs of investing in DTx solutions, whether there is a valuation bubble in the DTx space, and Will offers some advice for startups looking to raise funds. >>Click here to read the transcript Viewing in Apple Podcasts? Visit our website for links to everything below: https://digitalhealthtoday.com/dtx/ Guest Links and Resources: Connect with Will Gibbs: LinkedIn https://linkedin.com/in/willgibbs1/ Visit Octopus Ventures: Twitter | LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep19: Digital Therapy for Parkinson’s and Neurological Conditions

Ciara Clancy remembers the exact moment she decided to found Beats Medical; it was when she realized her Parkinson’s patient was 20 minutes late for metronome therapy because he was frozen at the door of the hospital, unable to take a single step. The metronome therapy, which helps Parkinson’s patients with their walking and movement, was only available in hospitals and via prescription. So Ciara decided to bring the therapy to them. Beats Medical turns a Parkinson’s patient’s phone into a medical device that gives live, visual feedback to help improve fine motor and gross motor skills, speech, and psychological well-being. Beats’ core technology has also been repurposed and deployed for other central nervous system (CNS) disorders and to help children cope with stress during the COVID-19 pandemic. Eugene and Ciara talk about some exciting recent developments in Beats’ product line, the evolution of their B2C and B2B models, and how Beats’ users have consistently driven the company to create better and more effective interventions. >>Click here to read the transcript Guest Links and Resources: Connect with Ciara Clancy: LinkedIn | Twitter Visit Beats Medical Ltd: Twitter | LinkedIn | YouTube| Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep18: Improving Outcomes for IBS and IBD Sufferers Through Light Touch Digital Therapy

As a former IBS sufferer, Elena Mustatea knows all too well that our standard model of healthcare does not adequately treat or support people with chronic conditions—especially digestive conditions. Elena eventually took matters into her own hands and attended a detox retreat in Thailand, which restored her physical and mental well-being and gave her the idea to start Bold Health. Bold Health is clinically validated and science-backed, and relieves the painful, life-disrupting symptoms of chronic digestive conditions through cognitive behavioral therapy and relaxation exercises. This intervention is crucial, because as Elena points out, 75% of the population suffers from GI symptoms in any given week, and 30% of the population has a diagnosable, long-term digestive condition. Digestive and autoimmune conditions are an enormous mental health burden and disproportionately affect women. Eugene and Elena talk about Elena’s journey from consulting and venture capital to digital therapeutics, Bold Health’s recent RCT results, and Elena’s view on how digital therapeutics and pharma could work together in the future. >>Click here to read the transcript Guest Links and Resources: Connect with Elena Mustatea: LinkedIn | Twitter Visit Bold Health: Twitter | LinkedIn | Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
April 27, 2021 by Digital Therapeutics Edition
Next Showing 1 - 8 of 159
X
X